Traditional Electronic Health Record (EHR) systems suffer from critical vulnerabilities in security, interoperability, and patient data control. This paper introduces PolyMed, a novel decentralized platform designed to address these challenges. PolyMed combines blockchain, Artificial Intelligence (AI), and edge computing into a synergistic architecture. It uses the Polygon blockchain for immutable record-keeping and a Decentralized Autonomous […]
Pressure rises on Novo as Innovent drug tops Ozempic
Innovent’s dual glucagon and GLP-1 agonist mazdutide outperforms Novo Nordisk’s Ozempic in overweight people with diabetes.
BridgeBio shifts filing plans for rare disease drug after Phase 3 success
BridgeBio on Monday trumpeted positive results from a Phase 3 rare disease study, potentially setting the company up with a stronger FDA pitch than it had originally thought. In the study’s interim analysis, BridgeBio’s drug …
UK watchdog slams AstraZeneca, Organon for marketing breaches
AstraZeneca and Organon have been found in serious breach of the U.K.’s pharma code, with a watchdog ruling that both companies brought discredit on the industry.
Neumora moves forward with NLRP3 in obesity after Ventyx’s drug failed to deliver weight loss
The “Really Big Neuroscience Company” is now also an obesity drug developer. Neumora is entering the pharma industry’s most lucrative sector by advancing an NLRP3 inhibitor days after a competitor said its drug with the …
Hemab nabs $157M to finance the ‘ultimate coagulation disorder’ biotech
A transatlantic drug developer with five projects in the oven, including two in clinical testing, has raised $157 million to try and push forward several advances in treating disorders related to blood clotting. The new …
Novartis makes $12bn wager on RNA drugs with Avidity buy
Novartis is poised to make one of its largest takeover deals in its history after agreeing to buy RNA specialist Avidity Biosciences for $12bn.
NHS hospitals trial 15-minute blood test to detect life-threatening conditions in children
NHS hospitals are piloting a rapid 15-minute blood test to distinguish viral vs bacterial infections in children, enabling faster diagnosis and treatment of serious illnesses like sepsis and meningitis NHS England is launching this winter trials of a groundbreaking 15-minute blood test in three hospitals, aimed at rapidly distinguishing between viral and bacterial infections in […]
Novo ended Akero deal talks before returning for $4.7B MASH acquisition
Novo Nordisk and a separate prospective buyer walked away from a potential acquisition of MASH drug developer Akero Therapeutics, before Novo came back to the table to finish the deal a few months later. …
Data protection, interoperability and governance assessment tool: results from a proof-of-concept survey
BackgroundThe Collaborative Health Information European Framework (CHIEF) supports consistent monitoring of quality of care and outcomes, through a cohesive information infrastructure aligned with legal and ethical standards, to ensure preparedness to the European Health Data Space (EHDS). We aimed to define, develop and apply a practical solution to help data controllers and data holders navigating […]